These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 35320978)

  • 1. Research Progress on Targeted Antioxidant Therapy and Vitiligo.
    Zhang J; Hu W; Wang P; Ding Y; Wang H; Kang X
    Oxid Med Cell Longev; 2022; 2022():1821780. PubMed ID: 35320978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
    Rojas-Urdaneta JE; Poleo-Romero AG
    Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitexin protects melanocytes from oxidative stress via activating MAPK-Nrf2/ARE pathway.
    Li XS; Tang XY; Su W; Li X
    Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):594-603. PubMed ID: 33045867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes.
    Qiao Z; Wang X; Xiang L; Zhang C
    Oxid Med Cell Longev; 2016; 2016():3401570. PubMed ID: 28018522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.
    Chang WL; Ko CH
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo.
    Lin X; Meng X; Song Z; Lin J
    Arch Biochem Biophys; 2020 Dec; 696():108670. PubMed ID: 33186606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of glutamine on human melanocyte oxidative stress model.
    Jiang L; Guo Z; Kong Y; Liang J; Wang Y; Wang K
    Indian J Dermatol Venereol Leprol; 2018; 84(3):269-274. PubMed ID: 29491190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway.
    Ma J; Li S; Zhu L; Guo S; Yi X; Cui T; He Y; Chang Y; Liu B; Li C; Jian Z
    Free Radic Biol Med; 2018 Dec; 129():492-503. PubMed ID: 30342186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity.
    Yu T; Wu Y; Lu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):147-151. PubMed ID: 38678613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water Buffalo (Bubalus bubalis) as a spontaneous animal model of Vitiligo.
    Singh VP; Motiani RK; Singh A; Malik G; Aggarwal R; Pratap K; Wani MR; Gokhale SB; Natarajan VT; Gokhale RS
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):465-9. PubMed ID: 27124831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible role of Wnt/β-catenin signalling in vitiligo treatment.
    Lin X; Meng X; Lin J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2208-2221. PubMed ID: 36912722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review.
    Białczyk A; Wełniak A; Kamińska B; Czajkowski R
    Mol Diagn Ther; 2023 Nov; 27(6):723-739. PubMed ID: 37737953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal hydrogen peroxide is not increased in lesional and non-lesional skin of vitiligo.
    Zailaie MZ
    Arch Dermatol Res; 2017 Jan; 309(1):31-42. PubMed ID: 27783153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated autophagy increased melanocyte sensitivity to H
    He Y; Li S; Zhang W; Dai W; Cui T; Wang G; Gao T; Li C
    Sci Rep; 2017 Feb; 7():42394. PubMed ID: 28186139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo.
    Elassiuty YE; Klarquist J; Speiser J; Yousef RM; El Refaee AA; Hunter NS; Shaker OG; Gundeti M; Nieuweboer-Krobotova L; Le Poole IC
    Exp Dermatol; 2011 Jun; 20(6):496-501. PubMed ID: 21426408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocytes as instigators and victims of oxidative stress.
    Denat L; Kadekaro AL; Marrot L; Leachman SA; Abdel-Malek ZA
    J Invest Dermatol; 2014 Jun; 134(6):1512-1518. PubMed ID: 24573173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.